Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states

Current Opinion in Pharmacology

Volumn 12, Issue 1, 2012, Pages 67-73

  Old, Elizabeth Amy ^a   Malcangio, Marzia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; DIACYLGLYCEROL; FRACTALKINE; G PROTEIN COUPLED RECEPTOR KINASE 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE C; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ALLODYNIA; CELL COMMUNICATION; CYTOKINE RELEASE; DYSESTHESIA; GLIA; HYPERALGESIA; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NEUROPATHIC PAIN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL GANGLION;

ANIMALS; CELL COMMUNICATION; CHEMOKINES; HUMANS; NEURALGIA; NEUROGLIA; NEURONS; SIGNAL TRANSDUCTION;

EID: 84857233639     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.10.015     Document Type: Review

References (48)

1. R. Baron Mechanisms of disease: neuropathic pain - a clinical perspective Nat Clin Pract Neurol 2 2006 95 106
2. J. Scholz, and C.J. Woolf The neuropathic pain triad: neurons, immune cells and glia Nat Neurosci 10 2007 1361 1368
3. S.B. McMahon, and M. Malcangio Current challenges in glia-pain biology Neuron 64 2009 46 54
4. E.A. Romero-Sandoval, R.J. Horvath, and J.A. DeLeo Neuroimmune interactions and pain: focus on glial-modulating targets Curr Opin Investig Drugs 9 2008 726 734
5. A. Bajetto, R. Bonavia, S. Barbero, and G. Schettini Characterization of chemokines and their receptors in the central nervous system: physiopathological implications J Neurochem 82 2002 1311 1329
6. T.J. Schall, and A.E. Proudfoot Overcoming hurdles in developing successful drugs targeting chemokine receptors Nat Rev Immunol 11 2011 355 363
7. P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hebert, R. Horuk, K. Matsushima, L.H. Miller, J.J. Oppenheim, and C.A. Power International union of pharmacology, XXII. Nomenclature for chemokine receptors Pharmacol Rev 52 2000 145 176
8. J.F. Bazan, K.B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D.R. Greaves, A. Zlotnik, and T.J. Schall A new class of membrane-bound chemokine with a CX3C motif Nature 385 1997 640 644
9. A.K. Clark, P.K. Yip, J. Grist, C. Gentry, A.A. Staniland, F. Marchand, M. Dehvari, G. Wotherspoon, J. Winter, and J. Ullah Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain Proc Natl Acad Sci USA 104 2007 10655 10660
10. E.D. Milligan, V. Zapata, M. Chacur, D. Schoeniger, J. Biedenkapp, K.A. O'Connor, G.M. Verge, G. Chapman, P. Green, and A.C. Foster Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats Eur J Neurosci 20 2004 2294 2302
11. G.M. Verge, E.D. Milligan, S.F. Maier, L.R. Watkins, G.S. Naeve, and A.C. Foster Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions Eur J Neurosci 20 2004 1150 1160
12. J.K. Harrison, Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R.K. McNamara, W.J. Streit, M.N. Salafranca, S. Adhikari, and D.A. Thompson Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia Proc Natl Acad Sci USA 95 1998 10896 10901
13. A. Nishiyori, M. Minami, Y. Ohtani, S. Takami, J. Yamamoto, N. Kawaguchi, T. Kume, A. Akaike, and M. Satoh Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429 1998 167 172
14. A.K. Clark, P.K. Yip, and M. Malcangio The liberation of fractalkine in the dorsal horn requires microglial cathepsin S J Neurosci 29 2009 6945 6954
15. J.A. Lindia, E. McGowan, N. Jochnowitz, and C. Abbadie Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain J Pain 6 2005 434 438
16. P.M. Hughes, M.S. Botham, S. Frentzel, A. Mir, and V.H. Perry Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS Glia 37 2002 314 327
17. Z.Y. Zhuang, Y. Kawasaki, P.H. Tan, Y.R. Wen, J. Huang, and R.R. Ji Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine Brain Behav Immun 21 2007 642 651
18. A.A. Staniland, A.K. Clark, R. Wodarski, O. Sasso, F. Maione, F. D'Acquisto, and M. Malcangio Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice J Neurochem 114 2010 1143 1157
19. S. Dalrymple, J. Grist, A.K. Clark, and M. Malcangio Systemic inhibition of cathepsin S attenuates vincristine-induced neuropathic hypersensitivity [abstract] Society for Neuroscience Abstracts/Annual Meetings Publications 2009
20. K.M. Lee, S.M. Jeon, and H.J. Cho Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK Eur J Pain 14 2010 682 712
21. S. Peregrin, M. Jurado-Pueyo, P.M. Campos, V. Sanz-Moreno, A. Ruiz-Gomez, P. Crespo, F. Mayor Jr., and C. Murga Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK Curr Biol 16 2006 2042 2047
22. N. Eijkelkamp, C.J. Heijnen, H.L. Willemen, R. Deumens, E.A. Joosten, W. Kleibeuker, I.J. den Hartog, C.T. van Velthoven, C. Nijboer, and M.A. Nassar GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain J Neurosci 30 2010 2138 2149
23. A. Kavelaars, N. Eijkelkamp, H.L. Willemen, H. Wang, A.G. Carbajal, and C.J. Heijnen Microglial GRK2: a novel regulator of transition from acute to chronic pain Brain Behav Immun 25 2011 1055 1060
24. A.K. Clark, A.A. Staniland, F. Marchand, T.K. Kaan, S.B. McMahon, and M. Malcangio P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide J Neurosci 30 2010 573 582
25. M.F. Jarvis, and B.S. Khakh ATP-gated P2X cation-channels Neuropharmacology 56 2009 208 215
26. E. Van Collie, J. Van Damme, and G. Opdenakker The MCP/eotaxin subfamily of CC chemokines Cytokine Growth Factor Rev 10 1999 61 86
27. J. Zhang, X.Q. Shi, S. Echeverry, J.S. Mogil, Y. De Koninck, and S. Rivest Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain J Neurosci 27 2007 12396 12406
28. J. Zhang, and Y. De Koninck Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury J Neurochem 97 2006 772 783
29. M.A. Dansereau, R.D. Gosselin, M. Pohl, B. Pommier, P. Mechighel, A. Mauborgne, W. Rostene, P. Kitabgi, N. Beaudet, P. Sarret, and S. Melik-Parsadaniantz Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats J Neurochem 106 2008 757 769
30. M.A. Thacker, A.K. Clark, T. Bishop, J. Grist, P.K. Yip, L.D. Moon, S.W. Thompson, F. Marchand, and S.B. McMahon CCL2 is a key mediator of microglia activation in neuropathic pain states Eur J Pain 13 2009 263 272
31. T. Tanaka, M. Minami, T. Nakagawa, and M. Satoh Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain Neurosci Res 48 2004 463 469
32. F.A. White, J. Sun, S.M. Waters, C. Ma, D. Ren, M. Ripsch, J. Steflik, D.N. Cortright, R.H. Lamotte, and R.J. Miller Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion Proc Natl Acad Sci USA 102 2005 14092 14097
33. C. Abbadie, J.A. Lindia, A.M. Cumiskey, L.B. Peterson, J.S. Mudgett, E.K. Bayne, J.A. DeMartino, D.E. MacIntyre, and M.J. Forrest Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Proc Natl Acad Sci USA 100 2003 7947 7952
34. Y.J. Gao, L. Zhang, O.A. Samad, M.R. Suter, K. Yasuhiko, Z.Z. Xu, J.Y. Park, A.L. Lind, Q. Ma, and R.R. Ji JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain J Neurosci 29 2009 4096 4108
35. J. Van-Steenwinckel, G.A. Reaux-Le, B. Pommier, A. Mauborgne, M.A. Dansereau, P. Kitabgi, P. Sarret, M. Pohl, and P.S. Melik CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury J Neurosci 31 2011 5865 5875
36. C.J. Olechowski, J.J. Truong, and B.J. Kerr Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE) Pain 141 2009 156 164
37. N. Saederup, A.E. Cardona, K. Croft, M. Mizutani, A.C. Cotleur, C.L. Tsou, R.M. Ransohoff, and I.F. Charo Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice PLoS ONE 5 2010 e13693
38. F. Knerlich-Lukoschus, M. Juraschek, U. Blomer, R. Lucius, H.M. Mehdorn, and J. Held-Feindt Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat J Neurotrauma 25 2008 427 448
39. R.D. Gosselin, C. Varela, G. Banisadr, P. Mechighel, W. Rostene, P. Kitabgi, and S. Melik-Parsadaniantz Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones J Neurochem 95 2005 1023 1034
40. Y. Kuang, Y. Wu, H. Jiang, and D. Wu Selective G protein coupling by C-C chemokine receptors J Biol Chem 271 1996 3975 3978
41. K. Biber, A. Sauter, N. Brouwer, S.C. Copray, and H.W. Boddeke Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC) Glia 34 2001 121 133
42. K. Biber, M. Tsuda, H. Tozaki-Saitoh, K. Tsukamoto, E. Toyomitsu, T. Masuda, H. Boddeke, and K. Inoue Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development EMBO J 30 2011 1864 1873
43. E.K. de Jong, J. Vinet, V.S. Stanulovic, M. Meijer, E. Wesseling, K. Sjollema, H.W. Boddeke, and K. Biber Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles FASEB J 22 2008 4136 4145
44. A. Rappert, K. Biber, C. Nolte, M. Lipp, A. Schubel, B. Lu, N.P. Gerard, C. Gerard, H.W. Boddeke, and H. Kettenmann Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia J Immunol 168 2002 3221 3226
45. K. Benamar, E.B. Geller, and M.W. Adler Elevated level of the proinflammatory chemokine, RANTES/CCL5, in the periaqueductal grey causes hyperalgesia in rats Eur J Pharmacol 592 2008 93 95
46. S.K. Bhangoo, D. Ren, R.J. Miller, D.M. Chan, M.S. Ripsch, C. Weiss, C. McGinnis, and F.A. White CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy Brain Behav Immun 21 2007 581 591
47. F. Knerlich-Lukoschus, dR-B. von, R. Lucius, H.M. Mehdorn, and J. Held-Feindt Spatiotemporal CCR1, CCL3(MIP-1alpha), CXCR4, CXCL12(SDF-1alpha) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain J Neurosurg Spine 14 2011 583 597
48. N.M. Wilson, H. Jung, M.S. Ripsch, R.J. Miller, and F.A. White CXCR4 signaling mediates morphine-induced tactile hyperalgesia Brain Behav Immun 25 2011 565 573